InnovationRx is your weekly digest of healthcare news. Sign up!
Wednesday, March 2, 2022
< + > If Medicare Part D Redesign Ever Happens, It Could Lead To Lower Prescription Drug Prices
Build Back Better probably isn’t completely dead. Parts of it may be resurrected. Given its bipartisan support, it’s likely that Medicare Part D restructuring would constitute an integral component of any passable legislation, which would likely exert downward pressure on drug prices.
< + > Federal Regulators Stop Planned Buyout Of Change Healthcare By UnitedHealthGroup
Just days before the deal was set to close, the US Department of Justice has filed a suit against UnitedHealthGroup to halt its planned acquisition of Change Healthcare, arguing that it could hurt competition between commercial health plans and undercut the market for claims processing technology. The suit was joined by Minnesota Attorney General Keith […]
< + > How to fight back against public health mis- and disinformation
At HIMSS22, Denise Scannell, MITRE's chief strategist for health communication, will offer insights into the many ways it's helping healthcare organizations and public health agencies combat false and inaccurate information.
< + > Risk Of Covid Hospitalization 5 Times Higher With Johnson & Johnson Shot Than Pfizer
Though less effective than Pfizer’s shot, the risk of hospitalization is still significantly higher for unvaccinated people.
< + > The evolution of healthcare data capture: Moving to clinical innovation
Donna M. Roach, CIO at University of Utah Health, offers lessons for better health information management in her upcoming HIMSS22 education session.
< + > Solving the 'empathy gap' with social media analytics
In a preview of her HIMSS22 session, Fran Ayalasomayajula discusses how the entire healthcare industry can play a role in making a patient feel prioritized.
Subscribe to:
Posts (Atom)